Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Brecht

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
MMW, Munchener Medizinische Wochenschrift|March 20, 1981
[Health care tasks of general practice]J G Brecht
Das Offentliche Gesundheitswesen|August 1, 1991
[Organizing public health reports]J G Brecht
Sozial- Und Praventivmedizin|January 1, 1989
[Diagnosis-specific hospital length of stay in Schleswig-Holstein]J G Brecht, A Jenke
Methods of Information in Medicine|January 1, 1987
A graphic method of estimating the specificity of screening programmes from incomplete follow-up dataJ G Brecht, B P Robra
Pharmacoeconomics|May 7, 1998
The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) StudyP K Schädlich, J G Brecht
International Journal of Epidemiology|September 1, 1984
Evaluation of German cancer screening by cross-sectional dataF W Schwartz, J G Brecht
Sozial- Und Praventivmedizin|January 1, 1997
[Cost-effectiveness analysis of prevention of reinfarction using low-dose acetylsalicylic acid; model calculation]P K Schädlich, J G Brecht
Pharmacoeconomics|April 5, 2000
Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in GermanyP K Schädlich, J G Brecht
Lebensversicherungs Medizin|February 10, 1984
[Cohort analysis of cancer mortality in the Federal Republic of Germany 1955 to 1979]B P Robra, J G Brecht
Pharmacoeconomics|October 4, 1996
Alcoholism. The cost of illness in the Federal Republic of GermanyJ G Brecht, F Poldrugo, P K Schädlich
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
MMW, Munchener Medizinische Wochenschrift|March 20, 1981
[Health care tasks of general practice]J G Brecht
Das Offentliche Gesundheitswesen|August 1, 1991
[Organizing public health reports]J G Brecht
Sozial- Und Praventivmedizin|January 1, 1989
[Diagnosis-specific hospital length of stay in Schleswig-Holstein]J G Brecht, A Jenke
Methods of Information in Medicine|January 1, 1987
A graphic method of estimating the specificity of screening programmes from incomplete follow-up dataJ G Brecht, B P Robra
Pharmacoeconomics|May 7, 1998
The cost effectiveness of acamprosate in the treatment of alcoholism in Germany. Economic evaluation of the Prevention of Relapse with Acamprosate in the Management of Alcoholism (PRAMA) StudyP K Schädlich, J G Brecht
International Journal of Epidemiology|September 1, 1984
Evaluation of German cancer screening by cross-sectional dataF W Schwartz, J G Brecht
Sozial- Und Praventivmedizin|January 1, 1997
[Cost-effectiveness analysis of prevention of reinfarction using low-dose acetylsalicylic acid; model calculation]P K Schädlich, J G Brecht
Pharmacoeconomics|April 5, 2000
Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in GermanyP K Schädlich, J G Brecht
Lebensversicherungs Medizin|February 10, 1984
[Cohort analysis of cancer mortality in the Federal Republic of Germany 1955 to 1979]B P Robra, J G Brecht
Pharmacoeconomics|October 4, 1996
Alcoholism. The cost of illness in the Federal Republic of GermanyJ G Brecht, F Poldrugo, P K Schädlich
Pageof 3